Literature DB >> 30342261

Characteristics of Opioid Prescriptions to Veterans With Cirrhosis.

Shari S Rogal1, Lauren A Beste2, Ada Youk3, Michael J Fine4, Bryan Ketterer5, Hongwei Zhang5, Steven Leipertz6, Maggie Chartier7, Chester B Good8, Kevin L Kraemer4, Matthew Chinman9, Timothy Morgan10, Walid F Gellad4.   

Abstract

BACKGROUND & AIMS: Despite increased risks for adverse effects in patients with cirrhosis, little is known about opioid prescriptions for this population. We aimed to assess time trends in opioid prescribing and factors associated with receiving opioids among patients with cirrhosis.
METHODS: Among Veterans with cirrhosis, identified using national Veterans Health Administration data (2005-2014), we assessed characteristics of patients and their prescriptions for opioids. We calculated the annual proportion of patients receiving any opioid prescription. Among opioid recipients, we assessed prescriptions that were long-term (>90 days' supply), for high doses (>100 MME/day), or involved combinations of opioids and acetaminophen or benzodiazepine. We evaluated patient characteristics independently associated with long-term and any opioid prescriptions using mixed-effects regression models.
RESULTS: Among 127,239 Veterans with cirrhosis, 97,974 (77.0%) received a prescription for an opioid. Annual opioid prescriptions increased from 36% in 2005 to 47% in 2014 (P < .01). Among recipients of opioids, the proportions of those receiving long-term prescriptions increased from 47% in 2005 to 54% in 2014 (P < .01), and19%-21% received prescriptions for high-dose opioids. Prescriptions for combinations of opioids and acetaminophen decreased from 68% in 2005 to 50% in 2014 (P < .01) and for combinations of opioids and benzodiazepines decreased from 24% to 19% over this time (P < .01). Greater probability of long-term opioid prescriptions was independently associated with younger age, female sex, white race, hepatitis C, prior hepatic decompensation, hepatocellular carcinoma, mental health disorders, nicotine use disorders, medical comorbidities, surgery, and pain-related conditions.
CONCLUSION: Among Veterans with cirrhosis, 36%-47% were prescribed opioids in each year. Mental health disorders and hepatic decompensation were independently associated with long-term opioid prescriptions.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Addiction; Analgesia; Chronic; Medication Safety; Narcotic

Mesh:

Substances:

Year:  2018        PMID: 30342261      PMCID: PMC8108399          DOI: 10.1016/j.cgh.2018.10.021

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  36 in total

1.  Up-regulation of central mu-opioid receptors in a model of hepatic encephalopathy: a potential mechanism for increased sensitivity to morphine in liver failure.

Authors:  Nora V Bergasa; Richard B Rothman; Erik Mukerjee; John Vergalla; E Anthony Jones
Journal:  Life Sci       Date:  2002-02-22       Impact factor: 5.037

2.  Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.

Authors:  Erin E Krebs; Amy Gravely; Sean Nugent; Agnes C Jensen; Beth DeRonne; Elizabeth S Goldsmith; Kurt Kroenke; Matthew J Bair; Siamak Noorbaloochi
Journal:  JAMA       Date:  2018-03-06       Impact factor: 56.272

3.  Association between opioid prescribing patterns and opioid overdose-related deaths.

Authors:  Amy S B Bohnert; Marcia Valenstein; Matthew J Bair; Dara Ganoczy; John F McCarthy; Mark A Ilgen; Frederic C Blow
Journal:  JAMA       Date:  2011-04-06       Impact factor: 56.272

4.  Trends in 30-Day and 1-Year Mortality Among Patients Hospitalized With Cirrhosis From 2004 to 2013.

Authors:  Fasiha Kanwal; Aylin Tansel; Jennifer R Kramer; Hua Feng; Steven M Asch; Hashem B El-Serag
Journal:  Am J Gastroenterol       Date:  2017-06-13       Impact factor: 10.864

5.  Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

Authors:  Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali
Journal:  Med Care       Date:  2005-11       Impact factor: 2.983

6.  Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.

Authors:  Lauren A Beste; Steven L Leipertz; Pamela K Green; Jason A Dominitz; David Ross; George N Ioannou
Journal:  Gastroenterology       Date:  2015-08-05       Impact factor: 22.682

7.  Decline in Prescription Opioids Attributable to Decreases in Long-Term Use: A Retrospective Study in the Veterans Health Administration 2010-2016.

Authors:  Katherine Hadlandsmyth; Hilary Mosher; Mark W Vander Weg; Brian C Lund
Journal:  J Gen Intern Med       Date:  2018-01-29       Impact factor: 5.128

Review 8.  Patient Outcomes in Dose Reduction or Discontinuation of Long-Term Opioid Therapy: A Systematic Review.

Authors:  Joseph W Frank; Travis I Lovejoy; William C Becker; Benjamin J Morasco; Christopher J Koenig; Lilian Hoffecker; Hannah R Dischinger; Steven K Dobscha; Erin E Krebs
Journal:  Ann Intern Med       Date:  2017-07-11       Impact factor: 25.391

9.  Gender differences in health care utilization among veterans with chronic pain.

Authors:  Suneet Kaur; Karen M Stechuchak; Cynthia J Coffman; Kelli D Allen; Lori A Bastian
Journal:  J Gen Intern Med       Date:  2007-02       Impact factor: 5.128

Review 10.  Opioid Drugs in Patients With Liver Disease: A Systematic Review.

Authors:  Hassan Soleimanpour; Saeid Safari; Kavous Shahsavari Nia; Sarvin Sanaie; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2016-03-06       Impact factor: 0.660

View more
  12 in total

Review 1.  Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy.

Authors:  Jeremy Louissaint; Sasha Deutsch-Link; Elliot B Tapper
Journal:  Clin Gastroenterol Hepatol       Date:  2022-08       Impact factor: 13.576

Review 2.  Assessment of Alcohol and Other Substance Use in Patients With Chronic Liver Disease.

Authors:  Rachel L Bachrach; Shari S Rogal
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-05-23

3.  Using Intervention Mapping to Develop a Novel Pain Self-Management Intervention for People with Cirrhosis.

Authors:  Shari S Rogal; Matthew J Chinman; William DeMonte; Sandra Gibson; Stephanie Hoyt-Trapp; Gloria J Klima; Naudia L Jonassaint; Jane M Liebschutz; Kevin L Kraemer; Jessica Merlin
Journal:  Dig Dis Sci       Date:  2022-02-11       Impact factor: 3.487

4.  Opioid prescriptions are associated with hepatic encephalopathy in a national cohort of patients with compensated cirrhosis.

Authors:  Andrew M Moon; Yue Jiang; Shari S Rogal; Elliot B Tapper; Sarah R Lieber; A Sidney Barritt
Journal:  Aliment Pharmacol Ther       Date:  2020-01-21       Impact factor: 8.171

5.  Opioid Avoidance After Liver Transplantation: The Ever-Shifting Pain Management Paradigm.

Authors:  Shari S Rogal
Journal:  Liver Transpl       Date:  2020-09-09       Impact factor: 5.799

6.  Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.

Authors:  Shari Rogal; Ada Youk; Olufunso Agbalajobi; Hongwei Zhang; Walid Gellad; Michael J Fine; Pamela Belperio; Timothy Morgan; Chester B Good; Kevin Kraemer
Journal:  Am J Gastroenterol       Date:  2021-07-01       Impact factor: 12.045

7.  Opioid and benzodiazepine prescription among patients with cirrhosis compared to other forms of chronic disease.

Authors:  Monica A Konerman; Mary Rogers; Brooke Kenney; Amit G Singal; Elliot Tapper; Pratima Sharma; Sameer Saini; Brahmajee Nallamothu; Akbar Waljee
Journal:  BMJ Open Gastroenterol       Date:  2019-04-14

8.  Incidence of and Risk Factors for Hepatic Encephalopathy in a Population-Based Cohort of Americans With Cirrhosis.

Authors:  Elliot B Tapper; James B Henderson; Neehar D Parikh; George N Ioannou; Anna S Lok
Journal:  Hepatol Commun       Date:  2019-09-06

9.  A scoping review to identify and map the multidimensional domains of pain in adults with advanced liver disease.

Authors:  Franklin F Gorospe; Laura Istanboulian; Martine Puts; David Wong; Elizabeth Lee; Craig M Dale
Journal:  Can J Pain       Date:  2020-09-15

10.  Patterns of Inpatient Opioid Use and Related Adverse Events Among Patients With Cirrhosis: A Propensity-Matched Analysis.

Authors:  Jessica B Rubin; Jennifer C Lai; Amy M Shui; Samuel F Hohmann; Andrew Auerbach
Journal:  Hepatol Commun       Date:  2021-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.